A multicenter phase II study of nivolumab combined with ipilimumab in patients with pediatric solid tumours in adulthood (GETHI021)

Mielgo Rubio, X.Diaz-Beveritge, R.Sepulveda Sanchez, J. M.Pineda, E.Vaz Salgado, M. A.Lecumberri, M. J.Valverde, C.Lopez Castro, R.Lopez, C.Virizuela Echaburu, J. A.Rodriguez Salas, N.de las Penas Bataller, R.Lopez Lopez, R.Medina Rodriguez, J.Rodriguez-Antona, C.Berraondo, P.Rodriguez-Moreno, J. F.Hurtado Nuno, A.Sevillano, E.Garcia-Donas, J.2025-01-072025-01-072020-09-010923-7534https://hdl.handle.net/10668/27614enA multicenter phase II study of nivolumab combined with ipilimumab in patients with pediatric solid tumours in adulthood (GETHI021)conference outputopen access10.1016/j.annonc.2020.08.11891569-8041http://www.annalsofoncology.org/article/S0923753420411858/pdf573469101357